NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy

NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy

Intensive, combination chemotherapy for malignant diseases causes a profound immunosuppression, which persists for the whole treatment period and after its completion. Impairment of the NK cells status may increase the risk of severe, disseminated infections and cancer. The aim of the study was the...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Jarosz, M, Hak, L, Wieckiewicz, J, Balcerska, A, Mysliwska, J
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Termedia Publishing House Ltd. 2009

Gelijkaardige items

Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma
door: Amandeep Aujla, et al.
Gepubliceerd in: (2019-04-01)

Evaluation of Bone Mineral Density in Children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin's Lymphoma (NHL): Chemotherapy with/without Radiotherapy
door: Ali Ghassemi, et al.
Gepubliceerd in: (2016-06-01)

Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
door: Miguel Enrique Cuéllar Mendoza, et al.
Gepubliceerd in: (2024-02-01)

Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin’s lymphoma and acute lymphoblastic leukemia
door: Betül Sevinir, et al.
Gepubliceerd in: (2011-03-01)

Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia
door: Betül Sevinir, et al.
Gepubliceerd in: (2011-03-01)

Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy
door: Seth E. Karol, et al.
Gepubliceerd in: (2021-07-01)

NK cell compartment in patients with coronary heart disease.
door: Hak, Ł, et al.
Gepubliceerd in: (2007)

Assessment of clinical immunogenicity of inotuzumab ozogamicin in patients with non-Hodgkin lymphoma and acute lymphoblastic leukemia
door: Darshana Jani, et al.
Gepubliceerd in: (2018-02-01)

Clinical pharmacokinetics of methotrexate in the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients
door: Škorić Biljana, et al.
Gepubliceerd in: (2020-01-01)

Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia
door: Marlise R. Luskin, et al.
Gepubliceerd in: (2025-02-01)

Changes in number of NK cells after one year from coronary artery bypass graft
door: Hak, L, et al.
Gepubliceerd in: (2009)

2448 The effect of allopurinol on pediatric patients undergoing maintenance chemotherapy for acute lymphoblastic leukemia or lymphoblastic lymphoma
door: Mariam M. Bhuiyan, et al.
Gepubliceerd in: (2018-06-01)

Linfoma No Hodgkin extranodal NK/T nasal Extranodal Non-Hodgkin NK/T nasal Lymphoma
door: Enrique Muñoz Hernández, et al.
Gepubliceerd in: (2019-05-01)

Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
door: Gustavo de Oliveira Canedo, et al.
Gepubliceerd in: (2025-02-01)

TO THE PROBLEM OF RADIATION-INDUCED CARCINOGENESIS AFTER TREATMENT OF HODGKIN’S LYMPHOMA AND ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN AND ADOLESCENTS
door: O. I. Scherbenko, et al.
Gepubliceerd in: (2016-02-01)

Differential Regulation of NK Cell Receptors in Acute Lymphoblastic Leukemia
door: Le Jie Lee, et al.
Gepubliceerd in: (2022-01-01)

The importance of intensive chemotherapy for advanced Hodgkin lymphoma in children
door: E.S. Belyaeva, et al.
Gepubliceerd in: (2020-06-01)

NK cell compartment in patients with coronary heart disease
door: Siebert Janusz, et al.
Gepubliceerd in: (2007-05-01)

Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma
door: Andrew D. Hughes, et al.
Gepubliceerd in: (2025-01-01)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
door: Luke Maese, et al.
Gepubliceerd in: (2022-06-01)

Combination chemotherapy for Hodgkin lymphoma
door: Alison J. Moskowitz
Gepubliceerd in: (2024-08-01)

Precursor NK cell lymphoblastic leukemia/lymphoma - report of a case with literature review
door: Sonal Jain, et al.
Gepubliceerd in: (2014-08-01)

The Effect of a New Glucose–Methotrexate Conjugate on Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma Cell Lines
door: Marta Woźniak, et al.
Gepubliceerd in: (2021-04-01)

Identification of methylation signatures associated with CAR T cell in B-cell acute lymphoblastic leukemia and non-hodgkin’s lymphoma
door: Jiwei Song, et al.
Gepubliceerd in: (2022-08-01)

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma
door: Andreas Engert, et al.
Gepubliceerd in: (2017-12-01)

Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy
door: Ling Ling Chua, et al.
Gepubliceerd in: (2020-02-01)

Acute myelofibrosis superseding B‐lymphoblastic leukemia/lymphoma
door: Siba El Hussein, et al.
Gepubliceerd in: (2023-11-01)

Evaluation of Chemotherapy Toxicity in Acute Lymphoblastic and Myelogenous Leukemia
door: Ardeshir Ghavamzadeh, et al.
Gepubliceerd in: (2012-04-01)

Evaluation of Chemotherapy Toxicity in Acute Lymphoblastic and Myelogenous Leukemia
door: Taher Entezari-Maleki, et al.
Gepubliceerd in: (2012-06-01)

Coexistence of T-cell lymphoblastic lymphoma and acute myeloid leukemia mimicking acute lymphocytic leukemia
door: Keyu Liu, et al.
Gepubliceerd in: (2018-01-01)

Genetic Variations of Tumor Necrosis Factor –α-308 and Lymphtoxin-α+252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients
door: Hajar Nasiri, et al.
Gepubliceerd in: (2013-09-01)

Hyperglycemia during induction chemotherapy of pediatric acute lymphoblastic leukemia
door: Shwetha Seetharam, et al.
Gepubliceerd in: (2016-01-01)

Clinical Profile and Induction Outcome of Children with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma
door: Awais Arshed, et al.
Gepubliceerd in: (2022-11-01)

Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib- based chemotherapy
door: Zhao J, et al.
Gepubliceerd in: (2015-06-01)

Participation in Physical Activity and Physical Education in School Among Children With Acute Lymphoblastic Leukemia After Intensive Chemotherapy
door: Hamidah Alias, et al.
Gepubliceerd in: (2019-03-01)

Ikaros Deletions among Bulgarian Patients with Acute Lymphoblastic Leukemia/Lymphoma
door: Stefan Lozenov, et al.
Gepubliceerd in: (2024-09-01)

Multilineage Lymphoblastic Lymphoma as an Initial Presentation of Mixed Phenotype Acute Leukemia
door: Mako Ikeda, et al.
Gepubliceerd in: (2023-01-01)

Methotrexate-induced chemical meningitis in patients with acute lymphoblastic leukemia/lymphoma
door: Linu A Jacob, et al.
Gepubliceerd in: (2015-01-01)

Sarcoid Reactions after Chemotherapy for Hodgkin's Lymphoma
door: Baldeep Wirk
Gepubliceerd in: (2010-01-01)

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
door: Guillermo eGervasini, et al.
Gepubliceerd in: (2012-11-01)